Daily Sepsis Research Analysis
Analyzed 41 papers and selected 3 impactful papers.
Summary
Analyzed 41 papers and selected 3 impactful articles.
Selected Articles
1. A human-specific long noncoding RNA regulator of antigen-presenting cell viability and antimicrobial defense.
This mechanistic study identifies SAILR, a primate-specific lncRNA induced during monocyte-to-macrophage differentiation and rapidly downregulated by bacterial challenge in an NF-κB–dependent manner. SAILR attenuates expression of adhesion, phagocytosis, and invasion genes (e.g., SIGLEC1, MMP7), positioning it as a regulator of macrophage viability and antimicrobial programs.
Impact: It uncovers a human/primate-specific RNA regulator linking infection sensing to macrophage functional reprogramming, advancing our understanding of immune homeostasis in sepsis-relevant contexts.
Clinical Implications: While preclinical, defining SAILR as an NF-κB–responsive brake on macrophage antimicrobial machinery suggests a potential target for host-directed immunomodulation in sepsis and severe infections.
Key Findings
- SAILR is a primate-specific lncRNA induced during monocyte-to-macrophage differentiation.
- Upon bacterial challenge, SAILR is rapidly downregulated via an NF-κB–dependent mechanism.
- SAILR dampens macrophage programs for adhesion, phagocytosis, and invasion, including reduced SIGLEC1 and MMP7 expression.
Methodological Strengths
- Mechanistic dissection of NF-κB–dependent regulation of a human/primate-specific lncRNA.
- Functional readouts linking lncRNA modulation to macrophage antimicrobial gene programs.
Limitations
- Abstract does not detail in vivo infection models or human clinical samples beyond expression programs.
- Translational relevance to patient outcomes in sepsis remains to be demonstrated.
Future Directions: Validate SAILR’s role in vivo across infection models, delineate interacting protein/RNA partners, and test therapeutic modulation for host-directed sepsis immunotherapy.
Macrophages are essential for both, to clear pathogens and preserve tissue homeostasis, yet the molecular regulators of this equilibrium remain incompletely defined. Here, we identify SAILR (survival associated immune-regulatory RNA), a primate-specific long noncoding RNA (lncRNA), as a critical modulator of macrophage viability under infection conditions. SAILR is induced during monocyte-to-macrophage differentiation, but rapidly downregulated upon bacterial challenge in a nuclear factor kappa B (NF-κB) dependent manner. In both naïve and immune-activated macrophages, SAILR dampens the expression of adhesion, phagocytosis, and invasion factors, which include SIGLEC1 and MMP7. During infection with
2. Lysosome-Induced Increase in Intracellular Granularity of Leukocytes: A Key Morphological Biomarker for Early Sepsis in Cell Population Data.
Using LPS-stimulated human whole blood and a murine LPS sepsis model, the study shows that lysosomal expansion increases leukocyte cytoplasmic granularity, mechanistically underpinning changes in hematology analyzer scattergram parameters. Elevated lysosomes raised N_WBC_SFL_W in leukocytes and D_Mon_SSC_W in monocytes, positioning these metrics as morphology-based biomarkers for early sepsis.
Impact: It provides a cellular-mechanistic basis for routinely available hematology analyzer parameters, enabling low-latency, scalable early sepsis detection and monitoring strategies.
Clinical Implications: N_WBC_SFL_W and D_Mon_SSC_W could be incorporated into early warning algorithms and therapeutic monitoring, particularly where advanced biomarkers are unavailable.
Key Findings
- Lysosomal content increases during sepsis are the primary cause of heightened leukocyte cytoplasmic granularity.
- Elevated lysosome counts increased N_WBC_SFL_W in leukocytes and D_Mon_SSC_W in monocytes under septic conditions.
- PKC and MyD88 pathway inhibition models were used in mice to probe signaling contributions to these morphological changes.
Methodological Strengths
- Integrated human in vitro and murine in vivo models to triangulate mechanisms.
- Direct quantification of lysosomal content linked to clinically available scattergram parameters.
Limitations
- LPS models may not capture the full complexity of human polymicrobial sepsis.
- Clinical diagnostic performance thresholds and prospective validation were not reported.
Future Directions: Prospective clinical validation of N_WBC_SFL_W and D_Mon_SSC_W thresholds, integration into sepsis early warning scores, and evaluation across diverse pathogens.
Early and rapid identification of sepsis is critical for improving clinical outcomes; however, reliable real-time biomarkers remain unavailable. The scattergram parameters of peripheral blood circulating leukocytes are altered during infection and sepsis. This study aims to explore the cellular biological characteristics underlying these changes, with a particular focus on morphological complexity. An in vitro human whole-blood infection model was constructed by stimulating isolated healthy human peripheral blood with lipopolysaccharide (LPS). Concurrently, a sepsis mouse model was established via intraperitoneal LPS injection. Subsequently, protein kinase C (PKC) and myeloid differentiation primary-response protein 88 (MyD88) inhibitors were administered separately to establish corresponding inhibition models in mice. The total lysosomal contents in leukocytes and monocytes were then detected to analyze the intrinsic mechanism responsible for the sepsis-associated changes in the scattergram parameters. The results indicated elevated lysosome counts in leukocytes raised N_WBC_SFL_W, whereas those in monocytes drove higher D_Mon_SSC_W under septic conditions. This study reveals that the increased lysosomal content is the primary cause of the heightened number of cytoplasmic granules in leukocytes during sepsis. Furthermore, it clarifies that the characteristic changes in the scattergram parameters N_WBC_SFL_W and D_Mon_SSC_W detected through hematological analysis are a consequence of alterations in the lysosomal content. Collectively, our finding demonstrate that sepsis-induced alterations in leukocytes are hematological manifestations of aberrant lysosomal expansion, providing novel mechanistic insights for sepsis diagnosis and potential therapeutic monitoring.
3. Sepsis-associated lymphopenia: Dynamic evaluation and its association with recurrent sepsis in critically ill patients.
In 4701 adults with sepsis or septic shock, early sustained deep lymphopenia (ALC ≤500/µL) over the first 48 hours showed a clear dose–response association with recurrent sepsis using Fine–Gray competing-risk models. Duration and cumulative burden (TWA-L ≤500/µL) outperformed milder thresholds and identify patients for early immune risk stratification.
Impact: Quantifies the prognostic value of depth and duration of lymphopenia for recurrent sepsis in a large cohort, addressing immune paralysis in sepsis trajectories.
Clinical Implications: Early immune monitoring incorporating duration-based ALC thresholds can flag high-risk patients for surveillance, infection control, and targeted immunoadjuvant strategies.
Key Findings
- Among 4701 patients, 9.1% developed recurrent sepsis; 20.8% died without recurrence.
- ALC ≤500/µL sustained for 1 or 2 days increased recurrent sepsis risk with adjusted sHRs of 1.61 and 2.22, respectively.
- A low 48-hour time-weighted average lymphocyte count (TWA-L ≤500/µL) independently predicted recurrence, whereas milder lymphopenia (≤1000/µL) showed weaker associations.
Methodological Strengths
- Large two-center cohort with 4701 patients and robust Fine–Gray competing-risk modeling.
- Dose–response assessment using both duration and cumulative burden metrics (days with ALC ≤500/µL, 48-h TWA-L).
Limitations
- Retrospective design may be subject to residual confounding and center-specific practices.
- Follow-up windows beyond the index hospitalization are not detailed in the abstract.
Future Directions: Prospective validation of ALC-based trajectories, integration with immune phenotyping (e.g., mHLA-DR), and interventional trials testing immune-adjuvant strategies in high-risk phenotypes.
OBJECTIVES: To evaluate whether early lymphocyte trajectories, integrating both the depth and duration of lymphopenia, predict recurrent sepsis in critically ill adults. DESIGN: Retrospective two-center cohort study. SETTING: Intensive care units of two tertiary hospitals. PATIENTS OR PARTICIPANTS: Adult patients admitted with sepsis or septic shock between January 2011 and July 2024. INTERVENTIONS: None. MAIN VARIABLES OF INTEREST: Early lymphopenia during the first 48 h was quantified as: (1) number of days with absolute lymphocyte count (ALC) ≤1000 or ≤500 cells/µL, and (2) 48-h time-weighted average lymphocyte count (TWA-L). Recurrent sepsis, defined as a new septic episode occurring ≥7 days after the index event, was analyzed using Fine-Gray competing-risk models, treating death without recurrence as a competing event. RESULTS: Among 4701 patients, 429 (9.1%) developed recurrent sepsis and 972 (20.8%) died without recurrence. Profound lymphopenia (ALC ≤ 500 cells/µL) showed a dose-response relationship: compared with 0 days, 1 and 2 days were associated with adjusted subdistribution hazard ratios (sHRs) of 1.61 (95% CI 1.22-2.13) and 2.22 (95% CI 1.74-2.84), respectively. Higher TWA-L ≤500/µL was also independently associated with increased risk, whereas milder lymphopenia (≤1000/µL) showed weaker and inconsistent associations. CONCLUSIONS: Early sustained deep lymphopenia (ALC ≤ 500/µL), quantified by duration or cumulative burden, identifies patients at increased risk of recurrent sepsis and may support early immune risk stratification.